Skip to main content
. 2013 Nov 1;8:4197–4213. doi: 10.2147/IJN.S50685

Figure 4.

Figure 4

Cell viability of the extracts of the scaffolds at different nano-HA contents.

Notes: *P<0.05 versus control; #P<0.05 versus pure PCL scaffolds.

Abbreviations: HA, hydroxyapatite; PCL, poly-ε-caprolactone.